Jon D Hoffmann
Examiner (ID: 9303, Phone: (571)272-9916 , Office: P/3746 )
Most Active Art Unit | 3746 |
Art Unit(s) | 3746 |
Total Applications | 82 |
Issued Applications | 44 |
Pending Applications | 0 |
Abandoned Applications | 38 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6638641
[patent_doc_number] => 20100035989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCOSITIS'
[patent_app_type] => utility
[patent_app_number] => 12/309430
[patent_app_country] => US
[patent_app_date] => 2007-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18904
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035989.pdf
[firstpage_image] =>[orig_patent_app_number] => 12309430
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/309430 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCOSITIS | Jul 18, 2007 | Abandoned |
Array
(
[id] => 4658274
[patent_doc_number] => 20080027136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Compositions and methods for the treatment of cystic fibrosis'
[patent_app_type] => utility
[patent_app_number] => 11/827362
[patent_app_country] => US
[patent_app_date] => 2007-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7199
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20080027136.pdf
[firstpage_image] =>[orig_patent_app_number] => 11827362
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/827362 | Compositions and methods for the treatment of cystic fibrosis | Jul 10, 2007 | Abandoned |
Array
(
[id] => 5304205
[patent_doc_number] => 20090298857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Treatment of Neurodegenerative Diseases Through Inhibition of HSP90'
[patent_app_type] => utility
[patent_app_number] => 12/307063
[patent_app_country] => US
[patent_app_date] => 2007-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16537
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298857.pdf
[firstpage_image] =>[orig_patent_app_number] => 12307063
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/307063 | Treatment of neurodegenerative diseases through inhibition of HSP90 | Jul 1, 2007 | Issued |
Array
(
[id] => 8555268
[patent_doc_number] => 08329738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Use of AMPK-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them'
[patent_app_type] => utility
[patent_app_number] => 12/373310
[patent_app_country] => US
[patent_app_date] => 2007-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16291
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12373310
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/373310 | Use of AMPK-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them | Jun 11, 2007 | Issued |
Array
(
[id] => 5166162
[patent_doc_number] => 20070287749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-13
[patent_title] => 'BROMFENAC OPHTHALMIC FORMULATIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 11/755662
[patent_app_country] => US
[patent_app_date] => 2007-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16289
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20070287749.pdf
[firstpage_image] =>[orig_patent_app_number] => 11755662
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/755662 | BROMFENAC OPHTHALMIC FORMULATIONS AND METHODS OF USE | May 29, 2007 | Abandoned |
Array
(
[id] => 6599692
[patent_doc_number] => 20100292266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase'
[patent_app_type] => utility
[patent_app_number] => 12/227756
[patent_app_country] => US
[patent_app_date] => 2007-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20793
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292266.pdf
[firstpage_image] =>[orig_patent_app_number] => 12227756
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/227756 | Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase | May 24, 2007 | Abandoned |
Array
(
[id] => 5343407
[patent_doc_number] => 20090182057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'DEUTERATED AMINOGLYCIDAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/302464
[patent_app_country] => US
[patent_app_date] => 2007-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29044
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20090182057.pdf
[firstpage_image] =>[orig_patent_app_number] => 12302464
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/302464 | DEUTERATED AMINOGLYCIDAL COMPOUNDS | May 24, 2007 | Abandoned |
Array
(
[id] => 6276343
[patent_doc_number] => 20100256217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'ANTIVIRAL INHIBITION OF CASEIN KINASE II'
[patent_app_type] => utility
[patent_app_number] => 12/301993
[patent_app_country] => US
[patent_app_date] => 2007-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15743
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256217.pdf
[firstpage_image] =>[orig_patent_app_number] => 12301993
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/301993 | ANTIVIRAL INHIBITION OF CASEIN KINASE II | May 21, 2007 | Abandoned |
Array
(
[id] => 5355557
[patent_doc_number] => 20090186901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'CHEMICAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/299204
[patent_app_country] => US
[patent_app_date] => 2007-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17012
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186901.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299204
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299204 | CHEMICAL COMPOUNDS | May 2, 2007 | Abandoned |
Array
(
[id] => 7687462
[patent_doc_number] => 20090176829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'BICYCLIC HETEROARYL COMPOUNDS AS PDE10 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/298782
[patent_app_country] => US
[patent_app_date] => 2007-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14624
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176829.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298782
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298782 | BICYCLIC HETEROARYL COMPOUNDS AS PDE10 INHIBITORS | Apr 25, 2007 | Abandoned |
Array
(
[id] => 5272397
[patent_doc_number] => 20090076173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Delivery System for a Hygienic Agent'
[patent_app_type] => utility
[patent_app_number] => 12/226503
[patent_app_country] => US
[patent_app_date] => 2007-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4197
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076173.pdf
[firstpage_image] =>[orig_patent_app_number] => 12226503
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/226503 | Delivery System for a Hygienic Agent | Apr 18, 2007 | Abandoned |
Array
(
[id] => 6516214
[patent_doc_number] => 20100216825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'FUNGICIDAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/296184
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8840
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216825.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296184
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296184 | FUNGICIDAL COMPOSITIONS | Apr 3, 2007 | Abandoned |
Array
(
[id] => 5279276
[patent_doc_number] => 20090131408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Organic Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/224734
[patent_app_country] => US
[patent_app_date] => 2007-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20436
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131408.pdf
[firstpage_image] =>[orig_patent_app_number] => 12224734
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/224734 | Organic compounds | Feb 20, 2007 | Issued |
Array
(
[id] => 5070372
[patent_doc_number] => 20070191474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'USE OF BENZO-FUSED HETEROCYLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE'
[patent_app_type] => utility
[patent_app_number] => 11/674021
[patent_app_country] => US
[patent_app_date] => 2007-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15127
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191474.pdf
[firstpage_image] =>[orig_patent_app_number] => 11674021
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/674021 | USE OF BENZO-FUSED HETEROCYLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE | Feb 11, 2007 | Abandoned |
Array
(
[id] => 14143115
[patent_doc_number] => 10251909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension
[patent_app_type] => utility
[patent_app_number] => 11/673497
[patent_app_country] => US
[patent_app_date] => 2007-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 9056
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11673497
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/673497 | Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension | Feb 8, 2007 | Issued |
Array
(
[id] => 8592026
[patent_doc_number] => 08349902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-08
[patent_title] => 'Pharmaceutical compositions useful for preventing and treating oncological diseases'
[patent_app_type] => utility
[patent_app_number] => 12/524961
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6645
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524961
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524961 | Pharmaceutical compositions useful for preventing and treating oncological diseases | Jan 28, 2007 | Issued |
Array
(
[id] => 5348908
[patent_doc_number] => 20090004269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Pharmaceutical Composition Comprising a Proton Pump Inhibitor and a Protein Component'
[patent_app_type] => utility
[patent_app_number] => 12/161247
[patent_app_country] => US
[patent_app_date] => 2007-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9981
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004269.pdf
[firstpage_image] =>[orig_patent_app_number] => 12161247
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/161247 | Pharmaceutical Composition Comprising a Proton Pump Inhibitor and a Protein Component | Jan 17, 2007 | Abandoned |
Array
(
[id] => 5954146
[patent_doc_number] => 20110034454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'MORPHOLINO PYRIMIDINE DERIVATIVES AND THEIR USE IN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/160752
[patent_app_country] => US
[patent_app_date] => 2007-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51277
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034454.pdf
[firstpage_image] =>[orig_patent_app_number] => 12160752
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/160752 | MORPHOLINO PYRIMIDINE DERIVATIVES AND THEIR USE IN THERAPY | Jan 7, 2007 | Abandoned |
Array
(
[id] => 5416976
[patent_doc_number] => 20090042863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Therapeutic Agent for Diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/087122
[patent_app_country] => US
[patent_app_date] => 2006-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11599
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042863.pdf
[firstpage_image] =>[orig_patent_app_number] => 12087122
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/087122 | Therapeutic Agent for Diabetes | Dec 26, 2006 | Abandoned |
Array
(
[id] => 5386293
[patent_doc_number] => 20090227538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'N-(Hetero)Aryl Indole Derivatives as Pesticides'
[patent_app_type] => utility
[patent_app_number] => 12/084503
[patent_app_country] => US
[patent_app_date] => 2006-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38005
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227538.pdf
[firstpage_image] =>[orig_patent_app_number] => 12084503
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/084503 | N-(Hetero)Aryl Indole Derivatives as Pesticides | Nov 1, 2006 | Abandoned |